venetoclax,olutasidenib,Cytarabine
rigel pharma,roche,abbvie,Forma Therapeutics
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'venetoclax', 'olutasidenib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'rigelpharma', 'rigel pharma']
$rigl announces presentation at #eha2023 of data from analysis of rezlidhia (olutasidenib) in 17 patients from the phase 2 study with mutant idh1 aml who had previously received venetoclax combination regimens. posters are available on 6/9 @ 9am cest. 
Rigel is a biotech company dedicated to discovering, developing and providing novel therapies for hematologic disorders and cancer.